Search Orphan Drug Designations and Approvals
-
| Generic Name: | Human cytomegalovirus immunoglobulin |
|---|---|
| Date Designated: | 12/20/2006 |
| Orphan Designation: | Prevention of congenital cytomegalovirus (CMV) infection following primary CMV infection in pregnant women |
| Orphan Designation Status: | Designated |
| FDA Orphan Approval Status: | Not FDA Approved for Orphan Indication |
| Sponsor: |
Biotest Pharmaceuticals Corporation's (BPC) 901 Yamato Road Suite 101 Boca Raton, Florida 33431 United States The sponsor address listed is the last reported by the sponsor to OOPD. |
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.
-







